Treatment of osteochondral defects of the talus by arthroscopic debridement and microfracturing: Long term follow-up

Treatment of osteochondral defects of the talus by arthroscopic debridement and microfracturing: Long term follow-up - Long term osteochondral defects

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32419

Enrollment

Registered

2008-07-01

Start date

2008-04-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteochondral defect

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with an osteochondral defect of the talus, who have been treated by means of arthroscopic debridement and microfracturing between 1988 and 2000.

Exclusion criteria

Exclusion criteria: Other surgical treatment of osteochondral defect of the talus (fixation, osteochondral autologous transplantation, autologous chondrocyte implantation), systemic disease (e.g. rheumatoid arthritis, lupus erythemadosus), inability to understand the patient information and the questionnaires (e.g. mental retardation, language barrier), ankle trauma 6 months or less before follow-up.

Design outcomes

Primary

Measure	Time frame
The primary outcome measure is the subjective outcome of the patients, measured by the Berndt & Harty Outcome score and the Ogilvie-Harris score.	—

Secondary

Measure	Time frame
Secondary outcome measures are the AOFAS-AHS score, the SF-36 score, classification of OCDs of the talus and osteoarthritis.	—

Countries

Netherlands

Outcome results